SIMILAR PATTERNS OF AMINO ACIDS FOR 3UCB_A_017A201_2

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1f5j BETA-1,4-XYLANASE

(Dictyoglomus
thermophilum)
PF00457
(Glyco_hydro_11)
5 GLY A  82
ILE A  62
GLY A  49
VAL A 153
VAL A 155
None
0.71A 3ucbB-1f5jA:
undetectable
3ucbB-1f5jA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fu1 DNA REPAIR PROTEIN
XRCC4


(Homo sapiens)
PF06632
(XRCC4)
5 LEU A 126
ALA A  42
GLY A  45
ILE A  34
VAL A 122
None
0.86A 3ucbB-1fu1A:
undetectable
3ucbB-1fu1A:
22.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ALA A  28
ASP A  29
GLY A  48
PRO A  81
VAL A  82
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 (-4.1A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
0.96A 3ucbB-1hvcA:
13.2
3ucbB-1hvcA:
38.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
VAL A  82
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 ( 3.9A)
A79  A 800 (-4.5A)
0.51A 3ucbB-1hvcA:
13.2
3ucbB-1hvcA:
38.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
VAL A  82
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.0A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
0.50A 3ucbB-1hvcA:
13.2
3ucbB-1hvcA:
38.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
VAL A  82
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 (-4.5A)
0.41A 3ucbB-1hvcA:
13.2
3ucbB-1hvcA:
38.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1igo FAMILY 11 XYLANASE

(Bacillus
subtilis)
PF00457
(Glyco_hydro_11)
5 GLY A  86
ILE A  66
GLY A  51
VAL A 156
VAL A 158
None
0.97A 3ucbB-1igoA:
undetectable
3ucbB-1igoA:
22.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1j0a 1-AMINOCYCLOPROPANE-
1-CARBOXYLATE
DEAMINASE


(Pyrococcus
horikoshii)
PF00291
(PALP)
5 LEU A  89
GLY A  47
GLY A 309
ILE A 311
VAL A  86
None
None
PLP  A 401 (-3.9A)
None
None
1.00A 3ucbB-1j0aA:
undetectable
3ucbB-1j0aA:
15.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1p1v SUPEROXIDE DISMUTASE
[CU-ZN]


(Homo sapiens)
PF00080
(Sod_Cu)
5 ALA A  95
VAL A  14
GLY A  16
ILE A  17
VAL A  87
None
0.78A 3ucbB-1p1vA:
undetectable
3ucbB-1p1vA:
26.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
VAL A  47
GLY A  49
ILE A  50
PRO A  81
None
0.40A 3ucbB-1sivA:
18.9
3ucbB-1sivA:
48.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tdj BIOSYNTHETIC
THREONINE DEAMINASE


(Escherichia
coli)
PF00291
(PALP)
PF00585
(Thr_dehydrat_C)
5 GLY A  65
ALA A  66
ILE A  83
GLY A  72
VAL A 154
None
0.98A 3ucbB-1tdjA:
undetectable
3ucbB-1tdjA:
11.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1to6 GLYCERATE KINASE

(Neisseria
meningitidis)
PF02595
(Gly_kinase)
5 GLY A 244
ALA A 243
ILE A 259
GLY A 250
ILE A 143
SO4  A 373 (-3.5A)
SO4  A 373 ( 4.2A)
None
None
None
0.86A 3ucbB-1to6A:
undetectable
3ucbB-1to6A:
16.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1txg GLYCEROL-3-PHOSPHATE
DEHYDROGENASE
[NAD(P)+]


(Archaeoglobus
fulgidus)
PF01210
(NAD_Gly3P_dh_N)
PF07479
(NAD_Gly3P_dh_C)
5 GLY A  78
ILE A 135
PRO A 118
VAL A 117
VAL A  84
None
1.01A 3ucbB-1txgA:
undetectable
3ucbB-1txgA:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tzb GLUCOSE-6-PHOSPHATE
ISOMERASE,
CONJECTURAL


(Pyrobaculum
aerophilum)
PF10432
(bact-PGI_C)
5 LEU A  54
ALA A 145
VAL A 128
ILE A  15
VAL A  51
None
0.96A 3ucbB-1tzbA:
undetectable
3ucbB-1tzbA:
15.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1u2e 2-HYDROXY-6-KETONONA
-2,4-DIENEDIOIC ACID
HYDROLASE


(Escherichia
coli)
PF12697
(Abhydrolase_6)
5 LEU A 281
GLY A  61
ALA A  60
ILE A  54
VAL A 277
None
0.86A 3ucbB-1u2eA:
undetectable
3ucbB-1u2eA:
17.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1w3f HEMOLYTIC LECTIN
FROM LAETIPORUS
SULPHUREUS


(Laetiporus
sulphureus)
PF03318
(ETX_MTX2)
5 GLY A 241
GLY A 296
ILE A 297
PRO A 221
VAL A 220
None
0.97A 3ucbB-1w3fA:
undetectable
3ucbB-1w3fA:
14.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1x7f OUTER SURFACE
PROTEIN


(Bacillus cereus)
PF05913
(DUF871)
5 GLY A  92
ALA A  93
ASP A  94
ILE A  55
VAL A  70
None
0.91A 3ucbB-1x7fA:
undetectable
3ucbB-1x7fA:
13.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1y8q UBIQUITIN-LIKE 2
ACTIVATING ENZYME
E1B


(Homo sapiens)
PF00899
(ThiF)
PF14732
(UAE_UbL)
PF16195
(UBA2_C)
5 LEU B 111
ILE B  44
GLY B  29
ILE B  28
VAL B  20
None
0.86A 3ucbB-1y8qB:
undetectable
3ucbB-1y8qB:
9.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yxy PUTATIVE
N-ACETYLMANNOSAMINE-
6-PHOSPHATE
2-EPIMERASE


(Streptococcus
pyogenes)
PF04131
(NanE)
6 LEU A 135
ILE A  73
VAL A 213
GLY A 211
PRO A  71
VAL A 104
None
1.09A 3ucbB-1yxyA:
undetectable
3ucbB-1yxyA:
23.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1z7s HUMAN COXSACKIEVIRUS
A21


(Enterovirus C)
PF00073
(Rhv)
5 GLY 2 188
ILE 2 127
VAL 2 230
GLY 2 123
ILE 2 197
None
0.91A 3ucbB-1z7s2:
undetectable
3ucbB-1z7s2:
18.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cy8 D-PHENYLGLYCINE
AMINOTRANSFERASE


(Pseudomonas
stutzeri)
PF00202
(Aminotran_3)
5 LEU A 258
GLY A 227
ALA A 228
ILE A 206
VAL A 260
None
0.70A 3ucbB-2cy8A:
undetectable
3ucbB-2cy8A:
13.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fko 173AA LONG
HYPOTHETICAL
FERRIPYOCHELIN
BINDING PROTEIN


(Pyrococcus
horikoshii)
PF00132
(Hexapep)
5 GLY A  88
ALA A  89
ILE A 109
VAL A 121
VAL A  91
None
0.82A 3ucbB-2fkoA:
undetectable
3ucbB-2fkoA:
21.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
PRO A  86
VAL A  87
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
0.36A 3ucbB-2fmbA:
15.2
3ucbB-2fmbA:
32.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gu0 NONSTRUCTURAL
PROTEIN 2


(Rotavirus C)
PF02509
(Rota_NS35)
5 LEU A 111
ASP A  70
ILE A  22
VAL A 106
VAL A 108
None
0.97A 3ucbB-2gu0A:
undetectable
3ucbB-2gu0A:
13.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2isq CYSTEINE SYNTHASE

(Arabidopsis
thaliana)
PF00291
(PALP)
5 GLY A 190
ALA A 189
GLY A 183
ILE A 180
PRO A 296
None
None
PLP  A 400 (-3.4A)
PLP  A 400 (-4.9A)
PLP  A 400 (-4.0A)
0.72A 3ucbB-2isqA:
undetectable
3ucbB-2isqA:
15.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2kvp TALIN-1

(Mus musculus)
PF08913
(VBS)
5 LEU A1923
GLY A1894
ALA A1897
VAL A1964
VAL A1920
None
0.87A 3ucbB-2kvpA:
undetectable
3ucbB-2kvpA:
18.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2nxg 2-DEHYDRO-3-DEOXYPHO
SPHOOCTONATE
ALDOLASE


(Aquifex
aeolicus)
PF00793
(DAHP_synth_1)
5 GLY A1144
ALA A1115
ILE A1098
VAL A1123
VAL A1121
None
0.99A 3ucbB-2nxgA:
undetectable
3ucbB-2nxgA:
18.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2oby PUTATIVE QUINONE
OXIDOREDUCTASE


(Homo sapiens)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 LEU A 145
GLY A 189
ALA A 188
ILE A 167
GLY A 185
None
1.02A 3ucbB-2obyA:
undetectable
3ucbB-2obyA:
15.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2odo ALANINE RACEMASE

(Pseudomonas
fluorescens)
PF00842
(Ala_racemase_C)
PF01168
(Ala_racemase_N)
5 GLY A 315
ALA A 314
ILE A 265
VAL A 286
VAL A 288
None
0.88A 3ucbB-2odoA:
undetectable
3ucbB-2odoA:
16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pyh POLY(BETA-D-MANNURON
ATE) C5 EPIMERASE 4


(Azotobacter
vinelandii)
PF12708
(Pectate_lyase_3)
5 GLY A 279
ALA A 280
ILE A 260
VAL A 224
VAL A 283
None
0.78A 3ucbB-2pyhA:
undetectable
3ucbB-2pyhA:
16.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
VAL A  47
GLY A  49
ILE A  50
PRO A  81
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.9A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-4.5A)
AB1  A 501 ( 4.9A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-4.2A)
0.48A 3ucbB-2rkfA:
20.5
3ucbB-2rkfA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rsp RSV PROTEASE

(Rous sarcoma
virus)
PF00077
(RVP)
6 LEU A  35
ASP A  37
GLY A  39
ALA A  40
ASP A  41
ILE A  44
None
0.25A 3ucbB-2rspA:
12.7
3ucbB-2rspA:
30.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3aqp PROBABLE SECDF
PROTEIN-EXPORT
MEMBRANE PROTEIN


(Thermus
thermophilus)
PF02355
(SecD_SecF)
PF07549
(Sec_GG)
5 GLY A 327
ALA A 329
GLY A 274
ILE A 271
VAL A 693
None
0.80A 3ucbB-3aqpA:
undetectable
3ucbB-3aqpA:
9.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ax6 PHOSPHORIBOSYLAMINOI
MIDAZOLE
CARBOXYLASE, ATPASE
SUBUNIT


(Thermotoga
maritima)
PF02222
(ATP-grasp)
5 LEU A  18
GLY A  13
ILE A 282
GLY A   5
ILE A  28
None
0.94A 3ucbB-3ax6A:
undetectable
3ucbB-3ax6A:
15.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ip1 ALCOHOL
DEHYDROGENASE,
ZINC-CONTAINING


(Thermotoga
maritima)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 GLY A 235
ALA A 236
GLY A 208
ILE A 203
VAL A 239
None
0.95A 3ucbB-3ip1A:
undetectable
3ucbB-3ip1A:
13.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jv7 ADH-A

(Rhodococcus
ruber)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 LEU A 211
GLY A 216
ALA A 217
ASP A 218
ILE A 190
None
0.69A 3ucbB-3jv7A:
undetectable
3ucbB-3jv7A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jx8 PUTATIVE LIPOPROTEIN

(Parabacteroides
distasonis)
PF10988
(DUF2807)
5 LEU A 177
ALA A 199
VAL A 231
ILE A 190
VAL A 196
None
0.99A 3ucbB-3jx8A:
undetectable
3ucbB-3jx8A:
18.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kke LACI FAMILY
TRANSCRIPTIONAL
REGULATOR


(Mycolicibacterium
smegmatis)
PF13377
(Peripla_BP_3)
5 ASP A 160
ILE A 278
GLY A 198
VAL A 276
VAL A 294
None
0.90A 3ucbB-3kkeA:
undetectable
3ucbB-3kkeA:
17.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kke LACI FAMILY
TRANSCRIPTIONAL
REGULATOR


(Mycolicibacterium
smegmatis)
PF13377
(Peripla_BP_3)
5 LEU A 330
ASP A 160
ILE A 278
GLY A 198
VAL A 294
None
0.87A 3ucbB-3kkeA:
undetectable
3ucbB-3kkeA:
17.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3m5r NONSTRUCTURAL
PROTEIN 1


(Influenza A
virus)
PF00600
(Flu_NS1)
5 GLY A 184
ILE A 128
VAL A 157
ILE A 160
VAL A 192
None
0.92A 3ucbB-3m5rA:
undetectable
3ucbB-3m5rA:
23.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mjf PHOSPHORIBOSYLAMINE-
-GLYCINE LIGASE


(Yersinia pestis)
PF01071
(GARS_A)
PF02843
(GARS_C)
PF02844
(GARS_N)
5 GLY A 273
ALA A 272
ILE A 252
VAL A 199
VAL A 251
None
1.01A 3ucbB-3mjfA:
undetectable
3ucbB-3mjfA:
12.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
VAL A  82
None
0.41A 3ucbB-3mwsA:
20.2
3ucbB-3mwsA:
70.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3noy 4-HYDROXY-3-METHYLBU
T-2-EN-1-YL
DIPHOSPHATE SYNTHASE


(Aquifex
aeolicus)
PF04551
(GcpE)
5 LEU A 198
GLY A 201
ILE A  23
GLY A 220
ILE A 221
None
0.76A 3ucbB-3noyA:
undetectable
3ucbB-3noyA:
15.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pl1 PYRAZINAMIDASE/NICOT
INAMIDASE PNCA
(PZASE)


(Mycobacterium
tuberculosis)
PF00857
(Isochorismatase)
5 LEU A 182
ALA A 143
VAL A   7
VAL A 157
VAL A 155
None
0.99A 3ucbB-3pl1A:
undetectable
3ucbB-3pl1A:
18.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pvl MYOSIN VIIA ISOFORM
1


(Mus musculus)
PF00784
(MyTH4)
5 ALA A1611
ASP A1623
ILE A1596
VAL A1631
VAL A1605
None
1.01A 3ucbB-3pvlA:
undetectable
3ucbB-3pvlA:
10.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3r3r FERRIPYOCHELIN
BINDING PROTEIN


(Salmonella
enterica)
PF00132
(Hexapep)
5 GLY A  55
ALA A  56
VAL A 169
GLY A  38
ILE A  39
None
0.94A 3ucbB-3r3rA:
undetectable
3ucbB-3r3rA:
19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3slz GAG-PRO-POL
POLYPROTEIN


(Murine leukemia
virus)
PF00077
(RVP)
6 LEU A  30
ASP A  32
GLY A  34
ALA A  35
VAL A  54
GLY A  56
None
3TL  A 126 (-2.4A)
3TL  A 126 (-3.1A)
3TL  A 126 ( 4.0A)
3TL  A 126 (-3.3A)
3TL  A 126 (-3.4A)
0.43A 3ucbB-3slzA:
11.3
3ucbB-3slzA:
26.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
VAL A  84
SO4  A 101 (-4.2A)
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.5A)
017  A 201 (-3.5A)
017  A 201 (-4.0A)
017  A 201 (-3.3A)
None
0.39A 3ucbB-3t3cA:
18.7
3ucbB-3t3cA:
69.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
VAL A  84
SO4  A 101 (-4.2A)
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.5A)
017  A 201 (-3.5A)
017  A 201 (-4.0A)
None
None
0.63A 3ucbB-3t3cA:
18.7
3ucbB-3t3cA:
69.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tis PROTEIN YRDA

(Escherichia
coli)
PF00132
(Hexapep)
5 GLY A  55
ALA A  56
VAL A 169
GLY A  38
ILE A  39
None
0.95A 3ucbB-3tisA:
undetectable
3ucbB-3tisA:
21.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
VAL A  47
GLY A  49
ILE A  50
PRO A  81
None
017  A 201 (-2.6A)
017  A 201 (-3.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
None
017  A 201 ( 4.9A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
017  A 201 (-4.1A)
0.41A 3ucbB-3ttpA:
19.9
3ucbB-3ttpA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
None
017  A 202 ( 2.5A)
017  A 201 (-3.4A)
017  A 201 ( 4.0A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
017  A 202 (-4.0A)
1.23A 3ucbB-3u7sA:
19.9
3ucbB-3u7sA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
GLY A  49
ILE A  50
PRO A  81
VAL A  84
None
017  A 202 ( 2.5A)
017  A 201 ( 3.5A)
017  A 201 (-3.4A)
017  A 201 (-3.2A)
None
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
017  A 202 (-4.0A)
None
0.51A 3ucbB-3u7sA:
19.9
3ucbB-3u7sA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3uhl PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
PRO A  81
VAL A  82
VAL A  84
None
0.40A 3ucbB-3uhlA:
16.6
3ucbB-3uhlA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3w03 DNA REPAIR PROTEIN
XRCC4


(Homo sapiens)
PF06632
(XRCC4)
5 LEU C 126
ALA C  42
GLY C  45
ILE C  34
VAL C 122
None
0.86A 3ucbB-3w03C:
undetectable
3ucbB-3w03C:
23.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wrv TM-1 PROTEIN

(Solanum
lycopersicum)
PF06792
(UPF0261)
5 ALA A 187
ILE A 120
VAL A  31
PRO A 143
VAL A 145
None
0.97A 3ucbB-3wrvA:
undetectable
3ucbB-3wrvA:
21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wry TM-1 PROTEIN

(Solanum
lycopersicum)
PF06792
(UPF0261)
5 ALA A 187
ILE A 120
VAL A  31
PRO A 143
VAL A 145
None
0.92A 3ucbB-3wryA:
undetectable
3ucbB-3wryA:
15.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wy7 8-AMINO-7-OXONONANOA
TE SYNTHASE


(Mycolicibacterium
smegmatis)
PF00155
(Aminotran_1_2)
5 GLY A 326
ALA A 327
VAL A 316
VAL A 372
VAL A 376
None
0.97A 3ucbB-3wy7A:
undetectable
3ucbB-3wy7A:
12.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hxc PUTATIVE GLYCOSYL
HYDROLASE


(Bacteroides
uniformis)
PF06439
(DUF1080)
5 LEU A 113
GLY A  75
ILE A 271
VAL A 287
VAL A 273
None
1.02A 3ucbB-4hxcA:
undetectable
3ucbB-4hxcA:
19.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jig DEHYDROGENASE

(Burkholderia
cenocepacia)
PF13561
(adh_short_C2)
5 GLY A 120
ALA A 121
GLY A  94
ILE A  95
VAL A 169
None
None
None
GOL  A 303 (-4.8A)
None
0.75A 3ucbB-4jigA:
undetectable
3ucbB-4jigA:
17.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
None
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
RIT  A 500 (-3.9A)
0.48A 3ucbB-4njvA:
20.0
3ucbB-4njvA:
79.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4o8q COATOMER SUBUNIT
DELTA


(Bos taurus)
PF00928
(Adap_comp_sub)
5 GLY A 345
ILE A 301
VAL A 483
VAL A 359
VAL A 361
None
0.97A 3ucbB-4o8qA:
undetectable
3ucbB-4o8qA:
18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4p99 MPAFP_RII
TETRA-TANDEMER


(Marinomonas
primoryensis)
no annotation 5 GLY A  97
ALA A  81
VAL A  30
VAL A  58
VAL A  45
None
0.98A 3ucbB-4p99A:
undetectable
3ucbB-4p99A:
11.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4p99 MPAFP_RII
TETRA-TANDEMER


(Marinomonas
primoryensis)
no annotation 5 GLY A 305
ALA A 289
VAL A 238
VAL A 266
VAL A 253
None
1.00A 3ucbB-4p99A:
undetectable
3ucbB-4p99A:
11.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pgh CAFFEIC ACID
O-METHYLTRANSFERASE


(Sorghum bicolor)
PF00891
(Methyltransf_2)
PF08100
(Dimerisation)
5 ASP A 283
ILE A 260
VAL A 254
VAL A 294
VAL A 292
None
0.90A 3ucbB-4pghA:
undetectable
3ucbB-4pghA:
15.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4r1i AMINOBENZOYL-GLUTAMA
TE TRANSPORTER


(Neisseria
gonorrhoeae)
PF03806
(ABG_transport)
5 LEU A 493
ILE A 455
VAL A  16
ILE A 409
VAL A 451
None
1.02A 3ucbB-4r1iA:
undetectable
3ucbB-4r1iA:
11.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ry8 PERIPLASMIC BINDING
PROTEIN


(Pseudothermotoga
lettingae)
PF13407
(Peripla_BP_4)
5 GLY A 230
ALA A 231
ILE A 159
GLY A 193
VAL A 220
None
1.02A 3ucbB-4ry8A:
undetectable
3ucbB-4ry8A:
15.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4w8y CRISPR SYSTEM CMR
SUBUNIT CMR2


(Pyrococcus
furiosus)
PF12469
(DUF3692)
5 GLY A 665
ILE A 691
VAL A 675
ILE A 596
VAL A 687
None
1.01A 3ucbB-4w8yA:
undetectable
3ucbB-4w8yA:
8.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4y0w YEAZ

(Pseudomonas
aeruginosa)
PF00814
(Peptidase_M22)
5 LEU A 211
ASP A  95
GLY A  71
ILE A  74
VAL A 213
None
0.77A 3ucbB-4y0wA:
undetectable
3ucbB-4y0wA:
16.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4y0w YEAZ

(Pseudomonas
aeruginosa)
PF00814
(Peptidase_M22)
5 LEU A 211
GLY A  63
GLY A  71
ILE A  74
VAL A 213
None
0.90A 3ucbB-4y0wA:
undetectable
3ucbB-4y0wA:
16.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
6 LEU A  30
ASP A  32
GLY A  34
ALA A  35
ASP A  36
GLY A  58
None
4B1  A 201 (-2.9A)
4B1  A 201 ( 4.6A)
4B1  A 201 (-3.6A)
4B1  A 201 (-4.4A)
4B1  A 201 (-3.4A)
0.42A 3ucbB-4ydfA:
13.0
3ucbB-4ydfA:
34.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
6 LEU A  30
ASP A  32
GLY A  34
ALA A  35
VAL A  56
GLY A  58
None
4B1  A 201 (-2.9A)
4B1  A 201 ( 4.6A)
4B1  A 201 (-3.6A)
None
4B1  A 201 (-3.4A)
0.52A 3ucbB-4ydfA:
13.0
3ucbB-4ydfA:
34.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zqg 1-DEOXY-D-XYLULOSE
5-PHOSPHATE
REDUCTOISOMERASE


(Moraxella
catarrhalis)
PF02670
(DXP_reductoisom)
PF08436
(DXP_redisom_C)
PF13288
(DXPR_C)
5 LEU A 137
GLY A 118
ALA A 117
ILE A  89
VAL A 138
None
0.74A 3ucbB-4zqgA:
undetectable
3ucbB-4zqgA:
15.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b18 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 GLY A  27
ALA A  28
ASP A  29
ILE A  32
PRO A  81
None
0.41A 3ucbB-5b18A:
18.0
3ucbB-5b18A:
73.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cj4 XRCC4-MYH7-(1562-162
2) CHIMERA PROTEIN


(Homo sapiens)
PF06632
(XRCC4)
5 LEU A 126
ALA A  42
GLY A  45
ILE A  34
VAL A 122
None
0.88A 3ucbB-5cj4A:
undetectable
3ucbB-5cj4A:
23.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hci GPN-LOOP GTPASE 1

(Saccharomyces
cerevisiae)
PF03029
(ATP_bind_1)
6 ASP A  40
GLY A 109
GLY A  15
PRO A  47
VAL A  46
VAL A  43
None
GDP  A 301 ( 4.4A)
GDP  A 301 (-3.0A)
None
None
None
1.32A 3ucbB-5hciA:
undetectable
3ucbB-5hciA:
17.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hs0 ANKYRIN DOMAIN
PROTEIN ANK1C4_7


(synthetic
construct)
PF12796
(Ank_2)
5 LEU A 121
GLY A 126
ALA A 127
ASP A 128
VAL A  86
None
0.87A 3ucbB-5hs0A:
undetectable
3ucbB-5hs0A:
19.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5irb RTX-ADHESIN

(Marinomonas
primoryensis)
no annotation 5 GLY A 487
ALA A 471
VAL A 420
VAL A 448
VAL A 435
None
1.00A 3ucbB-5irbA:
undetectable
3ucbB-5irbA:
15.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5it1 PUTATIVE CYTOCHROME
P450


(Streptomyces
peucetius)
PF00067
(p450)
5 GLY A 363
ILE A 118
PRO A 147
VAL A 146
VAL A 122
None
0.93A 3ucbB-5it1A:
undetectable
3ucbB-5it1A:
13.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5j0c SUPEROXIDE DISMUTASE
[CU-ZN],SUPEROXIDE
DISMUTASE
[CU-ZN],OXIDOREDUCTA
SE,SUPEROXIDE
DISMUTASE [CU-ZN]


(Homo sapiens)
PF00080
(Sod_Cu)
5 ALA A  39
VAL A 102
GLY A 104
ILE A 105
VAL A  31
None
0.93A 3ucbB-5j0cA:
undetectable
3ucbB-5j0cA:
30.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
None
0.41A 3ucbB-5t2zA:
20.7
3ucbB-5t2zA:
77.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ttk AMINE OXIDASE

(Pseudomonas
putida)
PF01593
(Amino_oxidase)
5 LEU A 449
ALA A  68
GLY A  73
VAL A 303
VAL A 305
None
0.85A 3ucbB-5ttkA:
undetectable
3ucbB-5ttkA:
13.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5uow N-METHYL-D-ASPARTATE
RECEPTOR SUBUNIT
NR1-8A


(Xenopus laevis)
PF00060
(Lig_chan)
PF01094
(ANF_receptor)
PF10613
(Lig_chan-Glu_bd)
5 GLY A 112
ALA A 111
ILE A  90
VAL A  78
VAL A 118
None
0.87A 3ucbB-5uowA:
undetectable
3ucbB-5uowA:
8.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5upr TRIOSEPHOSPHATE
ISOMERASE


(Toxoplasma
gondii)
PF00121
(TIM)
5 ALA A 280
ASP A 279
VAL A 324
VAL A 271
VAL A 275
None
0.99A 3ucbB-5uprA:
undetectable
3ucbB-5uprA:
18.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vat PENICILLIN-BINDING
PROTEIN ACTIVATOR
LPOA


(Haemophilus
influenzae)
PF04348
(LppC)
6 LEU A 261
GLY A 520
ALA A 523
ASP A 522
GLY A 359
VAL A 317
None
1.36A 3ucbB-5vatA:
undetectable
3ucbB-5vatA:
11.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xw3 O-ACETYLSERINE LYASE

(Bacillus
anthracis)
PF00291
(PALP)
5 ALA A  83
ILE A  67
GLY A  48
VAL A  92
VAL A  90
None
0.91A 3ucbB-5xw3A:
undetectable
3ucbB-5xw3A:
18.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5yid PLASMEPSIN II

(Plasmodium
falciparum)
no annotation 5 GLY A 283
ILE A 239
PRO A 242
VAL A 241
VAL A 248
None
0.94A 3ucbB-5yidA:
7.3
3ucbB-5yidA:
27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6arr ACETYL-COA
ACETYLTRANSFERASE


(Aspergillus
fumigatus)
no annotation 5 GLY A  22
ASP A 257
ILE A 206
VAL A 217
VAL A 219
None
1.02A 3ucbB-6arrA:
undetectable
3ucbB-6arrA:
22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cc2 CELL DIVISION
CONTROL PROTEIN 45
CDC45 PUTATIVE


(Entamoeba
histolytica)
no annotation 5 GLY A 396
ALA A 360
ILE A 206
VAL A  33
GLY A 381
None
0.98A 3ucbB-6cc2A:
undetectable
3ucbB-6cc2A:
19.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6eqn TRYPTOPHAN SYNTHASE
BETA CHAIN 2


(Sulfobacillus)
no annotation 5 GLY B 259
ALA B 290
ILE B 350
VAL B 342
VAL B 355
None
0.90A 3ucbB-6eqnB:
undetectable
3ucbB-6eqnB:
28.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6eqn TRYPTOPHAN SYNTHASE
BETA CHAIN 2


(Sulfobacillus)
no annotation 5 GLY B 259
ILE B 350
VAL B 342
GLY B 264
VAL B 355
None
None
None
PLP  B 501 (-3.6A)
None
1.03A 3ucbB-6eqnB:
undetectable
3ucbB-6eqnB:
28.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6fiv RETROPEPSIN

(Feline
immunodeficiency
virus)
PF00077
(RVP)
7 LEU A  28
ASP A  30
GLY A  32
ALA A  33
ASP A  34
ILE A  37
GLY A  58
None
3TL  A 201 (-3.5A)
3TL  A 201 (-3.4A)
3TL  A 201 (-4.0A)
3TL  A 201 (-3.9A)
3TL  A 201 ( 4.8A)
3TL  A 201 (-3.4A)
0.36A 3ucbB-6fivA:
15.9
3ucbB-6fivA:
32.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6fiv RETROPEPSIN

(Feline
immunodeficiency
virus)
PF00077
(RVP)
5 LEU A  28
ASP A  30
GLY A  32
ILE A  37
VAL A  99
None
3TL  A 201 (-3.5A)
3TL  A 201 (-3.4A)
3TL  A 201 ( 4.8A)
None
0.70A 3ucbB-6fivA:
15.9
3ucbB-6fivA:
32.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
5 LEU A  23
ASP A  25
ALA A  28
ILE A  32
VAL A  47
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
0.71A 3ucbB-6upjA:
18.3
3ucbB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
5 LEU A  23
ASP A  25
ALA A  28
VAL A  47
GLY A  49
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
0.75A 3ucbB-6upjA:
18.3
3ucbB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
6 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
0.61A 3ucbB-6upjA:
18.3
3ucbB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
5 LEU A  23
ASP A  25
GLY A  27
ASP A  29
ILE A  50
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 (-3.9A)
0.67A 3ucbB-6upjA:
18.3
3ucbB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
5 LEU A  23
ASP A  25
ILE A  32
VAL A  47
PRO A  81
None
NIU  A 100 (-2.8A)
None
None
None
0.62A 3ucbB-6upjA:
18.3
3ucbB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
6 LEU A  23
ASP A  25
VAL A  47
GLY A  49
ILE A  50
PRO A  81
None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
0.87A 3ucbB-6upjA:
18.3
3ucbB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
6 LEU A  23
ASP A  30
VAL A  47
GLY A  49
ILE A  50
PRO A  81
None
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
1.20A 3ucbB-6upjA:
18.3
3ucbB-6upjA:
49.49